|
|
| NDC Number | Brand Name | Generic Name | Labeler | Dosage Form | DEA Schedule | Marketing Start Date |
|---|---|---|---|---|---|---|
| 50474-980 | RYSTIGGO | ROZANOLIXIZUMAB | UCB, Inc. | INJECTION, SOLUTION | 2023-06-26 | |
| 50474-981 | RYSTIGGO | ROZANOLIXIZUMAB | UCB, Inc. | INJECTION, SOLUTION | 2024-06-14 | |
| 50474-982 | RYSTIGGO | ROZANOLIXIZUMAB | UCB, Inc. | INJECTION, SOLUTION | 2024-06-14 | |
| 50474-983 | RYSTIGGO | ROZANOLIXIZUMAB | UCB, Inc. | INJECTION, SOLUTION | 2024-06-14 | |
| 73475-1221 | VYVGART Hytrulo | efgartigimod alfa and hyaluronidase (human recombinant) | argenx US | INJECTION, SOLUTION | 2025-04-10 | |
| 73475-3041 | VYVGART | EFGARTIGIMOD ALFA | argenx US | INJECTION | 2021-12-17 | |
| 73475-3102 | VYVGART Hytrulo | efgartigimod alfa and hyaluronidase (human recombinant) | argenx US | INJECTION, SOLUTION | 2023-06-20 |
Loading full table content...